MedTrace Logo

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00899652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2017-04-26

No results posted yet for this study

Summary

RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at DNA in bone marrow and blood samples from young patients with acute myeloid leukemia or acute lymphoblastic leukemia.

Conditions

Interventions

GENETIC

Southern blotting

GENETIC

chromosomal translocation analysis

GENETIC

cytogenetic analysis

GENETIC

gene rearrangement analysis

GENETIC

mutation analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Beverly J. Lange, MD · Children's Hospital of Philadelphia

  • Carolyn A. Felix, MD · Children's Hospital of Philadelphia

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-01-31
Primary Completion
2005-09-30
Completion
2006-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899652 on ClinicalTrials.gov